glp-1 news updates november 2025 Novo Nordisk cuts forecast amid slower sales Retailers across the country are

Concurrently, Structure Therapeutics is advancing an APJ-targeting molecule into Phase 2 evaluation for obesity, suggesting that the target remains of clinical interest when candidate molecules are appropriately selected

When we contacted support twice to ask about long-term pricing, we received the same starting-price information already visible in the portal

Providers also know that gaining weight can worsen it, and losing weight can help improve it

But Lane and Karacabeyli agree that what is really needed is well-designed clinical trials in people with RA to find out if these medications truly reduce disease activity

Comments are reviewed for appropriate use of tone and language